



Continued genetic screening and analysis of
Arabidopsis mutants has extended our view of
brassinosteroid signaling beyond hormone percep-
tion to downstream events involving a negative cyto-
plasmic regulator and nuclear localized positive
activators of the brassinosteroid response.
Brassinosteroids are sterol-derived plant hormones
which have dramatic effects on the expansion, division
and differentiation of plant cells. The structural similar-
ity of brassinosteroids to animal and insect steroid hor-
mones led to predictions of similar signal transduction
pathways, including the presence in plants of homolo-
gous nuclear steroid receptors. However, direct exper-
imental approaches and analysis of the completed
Arabidopsis genome sequence have failed to provide
any evidence for such receptors. Instead, normal plant
growth and development requires the perception and
transduction of the brassinosteroid signal by a plasma
membrane-localized receptor kinase, encoded in Ara-
bidopsis by the BRASSINOSTEROID-INSENSITIVE1
(BRI1) gene [1]. Repeated genetic screens for mutants
defective in brassinosteroid response have until
recently uncovered only multiple alleles of bri1, each
with a characteristic mutant phenotype (Figure 1)
which in the case of severe alleles includes extreme
dwarfism, altered leaf morphology, delayed flowering
and senescence, male sterility and aberrant responses
when grown in darkness [2–5].
Molecular genetic and biochemical analyses of BRI1
have revealed a functional receptor kinase with a
leucine-rich repeat extracellular domain involved
directly or indirectly in brassinosteroid binding, and an
active cytoplasmic kinase domain that autophospho-
rylates on multiple serine and threonine residues [6–8].
Until very recently, however, no information was
available on events downstream of the initial perception
of brassinosteroids by BRI1. The inability to identify
mutations in non-BRI1 genes by genetic screens for
brassinosteroid insensitivity was thought to be due
either to redundancy in downstream components or to
lethality when loss-of-function mutations occurred in
one or more of these elements. A closer examination
of Arabidopsis dwarfs obtained in a genetic screen for
brassinosteroid insensitivity revealed a new mutant,
brassinosteroid-insensitive 2 (bin2), which in the homo-
zygous state closely resembles the bri1 phenotype but
which results from a lesion in a distinct genetic locus.
Moreover, while bri1 alleles are all recessive loss-of-
function mutations, bin2 is a semi-dominant gain-of-
function mutant [9].
BIN2 has now been cloned, and was found to encode
a cytoplasmic serine/threonine kinase, the catalytic
domain of which shares 70% sequence similarity with
the Drosophila shaggy kinase and mammalian glyco-
gen synthase kinase-3 (GSK-3) [10]. GSK-3/shaggy-
like kinases are found widely among eukaroytes and
are often negative regulators of signal transduction
pathways controlling metabolism and developmental
events such as cell-fate determination and pattern for-
mation [11]. In mammals, GSK-3 phos-phorylates and
inactivates glycogen synthase: insulin initiates a
cascade of events that results in the phosphorylation
and inactivation of GSK-3 and the subsequent activa-
tion of glycogen synthase, which then converts glucose
to glycogen. During early devel-opment of inverte-
brates and vertebrates, GSK-3/shaggy kinases nega-
tively regulate the Wingless/Wnt signaling pathway by
phosphorylating β-catenin, inducing its proteasome-
dependent degradation. When the proper develop-
mental signal is perceived by a seven-pass trans-
membrane Frizzled family receptor, the GSK-3/shaggy
kinase is inactivated resulting in accumulation of 
β-catenin, which moves to the nucleus where it partic-
ipates in trans-activation of a set of genes essential for
developmental pattern formation [11].
In view of the roles GSK-3/shaggy kinases play as
negative regulators of several eukaryotic signal trans-
duction pathways, it is perhaps not surprising that
BIN2 has been shown by biochemical and genetic
analysis to be a negative regulator of brassinosteroid
signal transduction. The appearance of a bri1-like phe-
notype in transgenic plants expressing BIN2 was found
to correlate with the level of BIN2 transcripts, with the
highest overexpression lines showing the most severe
phenotype. Furthermore, recombinant BIN2 kinase car-
rying the bin2 mutation was more active in a peptide
kinase assay than the wild-type recombinant protein
[10]. Thus, bin2 appears to be a hypermorphic mutant
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Figure 1. Comparison of brassinosteroid-insensitive 1 (bri1)
and wild-type Arabidopsis thaliana phenotypes.
The two plants shown are both light-grown and are of the same
age: the bri1 mutant on the left shows characteristic extreme
dwarfism and dark-green curled leaves; bri1 mutants also
exhibit delayed senescence and flowering, and are male sterile.
whose increased GSK-3/shaggy kinase activity nega-
tively affects brassinosteroid signaling, even in the
presence of an active BRI1 receptor kinase.
By analogy with the Wingless/Wnt pathway, BIN2
might act by phosphorylating, and inactivating an
important positive regulator of brassinosteroid signal
transduction. BIN2 itself would be inactivated by a
cascade of events initiated by brassinosteroid binding
to BRI1 (or a BRI1-containing complex). If this is
correct, understanding the detailed mechanisms of
brassinosteroid signaling will require identification of
upstream and downstream interacting partners of BIN2.
Repeated genetic and biochemical experiments have
shown that BRI1 is unlikely to phosphorylate BIN2
directly, and thus intermediate steps — as occur in the
Wingless/Wnt pathway — will be required between
receptor activation and shaggy kinase inactivation [10].
With respect to downstream events, Arabidopsis
apparently does not encode proteins closely related to
β-catenin. But two novel proteins that are potential
substrates of BIN2 shaggy kinase have recently been
identified in genetic screens for suppressors of bri1
mutants and for plants resistant to the brassinosteroid
biosynthesis inhibitor, brassinazole [12,13]. The bri1-
EMS-suppressor 1-D (bes1-D) and brassinazole resis-
tant 1-D (bzr1-D) mutants exhibit constitutive brass-
inosteroid responses with phenotypes independent
both of brassinosteroid levels and an active BRI1
receptor. The BES1 and BZR1 genes encode closely
related proteins of unknown function: they exhibit 88%
sequence identity, including bipartite nuclear localiza-
tion signals and multiple consensus sites (S/TXXXS/T)
for phosphorylation by GSK-3 kinases. BIN2 kinase
strongly phosphorylates recombinant BES1 in vitro,
and in vivo studies showed that BIN2 negatively affects
BES1 protein levels [12]. Moreover, BES1 and BZR1
are found both in the cytoplasm and nucleus, and their
nuclear localization is rapidly and significantly enhanced
by brassinosteroid treatment but not, at least in the
case of BES1, by other plant hormones.
A possible biological significance for this nuclear
localization is suggested by the fact that several
genes encoding wall-modifying enzymes involved in
cell expansion are overexpressed in bes1-D mutants
[12]. Furthermore, the extent of nuclear localization of
BZR1 is correlated with the most actively expanding
zones of dark-grown Arabidopsis hypocotyls [13].
While BES1 and BZR1 appear to have overlapping
functions, they are not completely redundant, as
bes1-D and bzr1-D mutant plants differ in their light-
grown phenotypes and in the extent of feedback inhi-
bition of brassinosteroid biosynthesis.
The emerging picture of brassinosteroid signal
transduction reveals a pathway that shares much of
the logic of Wnt signaling in vertebrates and inverte-
brates (Figure 2). After plasma membrane perception
by brassinosteroids, an unknown number of steps
leads to inactivation of the negative regulator BIN2,
which allows the unphosphorylated form of BES1 (and
BZR1?) to accumulate and translocate to the nucleus.
These proteins then activate the expression of brassi-
nosteroid response genes by an unknown mechanism.
It should be noted that, thus far, only the BIN2 shaggy-
like kinase has been shown to have actual sequence
homology to components of the Wnt pathway.
Lastly, GSK-3/shaggy kinases are known to have
roles in other signaling pathways in many eukaryotes
[14] and an independent genetic analysis of Ara-
bidopsis ucu1 mutants — allelic to bin2 — suggests
that the BIN2/UCU1 kinase may also be involved in
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Figure 2. Parallel signal transduction logic
of the brassinosteroid and Wnt pathways.
The BIN2 kinase of Arabidopsis shares
70% amino acid identity in the catalytic
domain with GSK3/shaggy kinases of ver-
tebrates and invertebrates. These kinases
are cytoplasmic and act to negatively reg-
ulate signaling by phosphorylating posi-
tive regulators of the pathway. Ligand
binding to cell surface receptors initiates
a signaling cascade that inactivates the
BIN2/GSK3 kinases and allows accumula-
tion and nuclear localization of the
unphosphorylated form of the positive
regulators BES1/BZR1 and β-catenin.
Steps that have a positive effect on sig-
naling are shown in blue, while those with
a negative effect are in red. For simplicity
not all steps and known accessory pro-
teins in the Wnt pathway are shown.
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transducing the signal from auxin, another plant
hormone that controls cell expansion and overall
growth [15]. Interestingly, bes1-D mutants also over-
express genes previously identified as rapidly inducible
by auxin [12]. Thus, a complete understanding of sig-
naling pathways controlling cell expansion will require
cataloging all of the BIN2-interacting proteins, as well
as clarifying the mechanisms of gene activation by
BES1 and BZR1. Furthermore, at least 10 shaggy-like
kinases are encoded in the Arabidopsis genome [16],
and it is currently not known if any besides BIN2 are
involved in hormone signaling. Connecting the steps
between BRI1 and BIN2 and identifying response ele-
ments in the promoters of brassinosteroid-regulated
genes, are further challenges in completing the picture
of steroid hormone signaling in plants.
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